Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
ABBOTT BIORESEARCH
WORCESTER, MA US
1. 20110008766 Dual Variable Domain Immunoglobulins and Uses Thereof 01-13-20112. 20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof 10-14-2010
3. 20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof 09-16-2010
4. 20100221179 IL-1 Binding Proteins - The present invention encompasses IL-1 09-02-2010
5. 20100216762 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof 08-26-2010
6. 20100104563 ANTIBODIES THAT BIND IL-18 AND METHODS OF INHIBITING IL-18 ACTIVITY 04-29-2010
7. 20100076178 Dual Variable Domain Immumoglobulins and Uses Thereof 03-25-2010
8. 20100074900 PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF 03-25-2010
9. 20100041676 Kinase inhibitors - The present application is directed to compounds of the formula STR00001 wherein the substituents are as defined herein 02-18-2010
10. 20100040537 Prostaglandin E2 Binding Proteins and Uses Thereof 02-18-2010
11. 20100034823 Crystalline anti-hTNFalpha antibodies - batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said 02-11-2010
12. 20090312338 Novel Tricyclic Compounds - compound of Formula STR00001 pharmaceutically acceptable salts pro-drugs biologically active metabolites 12-17-2009
13. 20090311253 Dual Variable Domain Immunoglobulins and Uses Thereof 12-17-2009
14. 20090304693 Dual Variable Domain Immunoglobulins and Uses Thereof 12-10-2009
15. 20090270402 Novel triazolopyridazines - novel compounds of formula STR00001 wherein the variables are defined as herein 10-29-2009
16. 20090232736 Dual specificity antibodies and methods of making and using 09-17-2009
17. 20090209609 Thienopyrroles and pyrrolothiazoles as new therapeutic agents 08-20-2009
18. 20090202557 Compositions and methods for crystallizing antibody fragments 08-13-2009
19. 20090148513 Compositions and methods for crystallizing antibodies 06-11-2009
20. 20090118298 Octahydropentalene compounds as chemokine receptor antagonists 05-07-2009
21. 20090069288 Novel therapeutic compounds - Disclosed herein are novel compounds of Formula , STR00001 wherein the variables are defined as herein 03-12-2009
22. 20090068172 Compositions and methods comprising binding proteins for adalimumab 03-12-2009
23. 20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds 01-29-2009
24. 20080292642 Crystalline anti-human IL-12 antibodies - batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the 11-27-2008
25. 20080280876 Novel oxadiazole compounds - pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or 11-13-2008
26. 20080255367 Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane-carboxylates 10-16-2008
27. 20080249305 Novel imidazole based heterocycles - novel imidazopyrazine compounds useful as kinase inhibitors and as such would be useful in treating certain 10-09-2008
28. 20080242862 Novel imidazo based heterocycles - novel imidazopyrazine compounds useful as kinase inhibitors and as such would be useful in treating certain 10-02-2008
29. 20080227704 CXCL13 binding proteins - The present invention encompasses CXCL13 binding proteins 09-18-2008